Leveraged buyout transaction
Probably, Dr. Chain and the board, already at Feb. 13, 2013 in their business plan (see letter to shareholder) had planned the creation of a New Company (Chain Pharmaceuticals).
New Company to make a leveraged buyout transaction to acquire all the ILNS shares, held mostly by big basher and restore oxygen to Intellect.
Therefore, I believe a possible buyot by Dr. Chain with financing from banks, funds or other ...
Shareholders do not worry if the project goes in port, Chain Pharmaceuticals and Intellect will be a single company. In addition, the letter of intent signed by Dr. Chain with Chiesi Pharma, will lead to the final signature with Intellect to acquire the rights of CHF5074. Of course, will also be possible partnerships with big Pharma at the same time.
The leveraged buyout usually involves the creation of a special purpose vehicle set up ad hoc and called NewCo ( Chain Pharmaceuticals ), in which the sponsors of the operation and the various lenders entering the venture capital and debt capital necessary for the acquisition.
.
